IL142153A0 - Non-endogenous, constitutively activated human g protein-coupled receptors - Google Patents
Non-endogenous, constitutively activated human g protein-coupled receptorsInfo
- Publication number
- IL142153A0 IL142153A0 IL14215399A IL14215399A IL142153A0 IL 142153 A0 IL142153 A0 IL 142153A0 IL 14215399 A IL14215399 A IL 14215399A IL 14215399 A IL14215399 A IL 14215399A IL 142153 A0 IL142153 A0 IL 142153A0
- Authority
- IL
- Israel
- Prior art keywords
- endogenous
- protein
- coupled receptors
- activated human
- constitutively activated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (33)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/170,496 US6555339B1 (en) | 1997-04-14 | 1998-10-13 | Non-endogenous, constitutively activated human protein-coupled receptors |
US10802998P | 1998-11-12 | 1998-11-12 | |
US10921398P | 1998-11-20 | 1998-11-20 | |
US11006098P | 1998-11-27 | 1998-11-27 | |
US12041699P | 1999-02-16 | 1999-02-16 | |
US12185299P | 1999-02-26 | 1999-02-26 | |
US12394699P | 1999-03-12 | 1999-03-12 | |
US12395199P | 1999-03-12 | 1999-03-12 | |
US12394899P | 1999-03-12 | 1999-03-12 | |
US12394599P | 1999-03-12 | 1999-03-12 | |
US12394999P | 1999-03-12 | 1999-03-12 | |
US12394499P | 1999-03-12 | 1999-03-12 | |
US13712799P | 1999-05-28 | 1999-05-28 | |
US13643999P | 1999-05-28 | 1999-05-28 | |
US13643699P | 1999-05-28 | 1999-05-28 | |
US13713199P | 1999-05-28 | 1999-05-28 | |
US13643799P | 1999-05-28 | 1999-05-28 | |
US13656799P | 1999-05-28 | 1999-05-28 | |
US14144899P | 1999-06-29 | 1999-06-29 | |
US15111499P | 1999-08-27 | 1999-08-27 | |
US15252499P | 1999-09-03 | 1999-09-03 | |
US15663399P | 1999-09-29 | 1999-09-29 | |
US15663499P | 1999-09-29 | 1999-09-29 | |
US15655599P | 1999-09-29 | 1999-09-29 | |
US15665399P | 1999-09-29 | 1999-09-29 | |
US15729499P | 1999-10-01 | 1999-10-01 | |
US15728299P | 1999-10-01 | 1999-10-01 | |
US15728099P | 1999-10-01 | 1999-10-01 | |
US15728199P | 1999-10-01 | 1999-10-01 | |
US15729399P | 1999-10-01 | 1999-10-01 | |
US41704499A | 1999-10-12 | 1999-10-12 | |
US41676099A | 1999-10-12 | 1999-10-12 | |
PCT/US1999/024065 WO2000022131A2 (en) | 1998-10-13 | 1999-10-13 | Non-endogenous, constitutively activated human g protein-coupled receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL142153A0 true IL142153A0 (en) | 2002-03-10 |
Family
ID=27586908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14215399A IL142153A0 (en) | 1998-10-13 | 1999-10-13 | Non-endogenous, constitutively activated human g protein-coupled receptors |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR20010080882A (en) |
CA (1) | CA2348688A1 (en) |
IL (1) | IL142153A0 (en) |
NZ (1) | NZ510712A (en) |
WO (1) | WO2000022131A2 (en) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
US7119190B2 (en) | 1997-04-14 | 2006-10-10 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human G protein-coupled receptors |
WO1999024569A1 (en) * | 1997-11-11 | 1999-05-20 | Ono Pharmaceutical Co., Ltd. | Human lysophosphatidic acid receptor and use thereof |
WO1999046378A1 (en) | 1998-03-12 | 1999-09-16 | Yamanouchi Pharmaceutical Co., Ltd. | Novel g protein-coupled receptor proteins |
US7094593B1 (en) | 1998-09-01 | 2006-08-22 | Basf Aktiengesellschaft | Method for improving the function of heterologous G protein-coupled receptors |
EP1155031A4 (en) * | 1998-11-03 | 2002-11-27 | Smithkline Beecham Corp | Axor14, a g-protein coupled receptor |
USRE42190E1 (en) | 1998-11-20 | 2011-03-01 | Arena Pharmaceuticals, Inc. | Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
US20030017528A1 (en) | 1998-11-20 | 2003-01-23 | Ruoping Chen | Human orphan G protein-coupled receptors |
US7816492B2 (en) | 1998-11-20 | 2010-10-19 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors |
CA2348377C (en) * | 1998-11-20 | 2008-12-02 | Arena Pharmaceuticals, Inc. | Human orphan g protein-coupled receptors |
US6221660B1 (en) | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
EP1189944A4 (en) * | 1999-06-21 | 2002-09-11 | Smithkline Beecham Corp | Axor16, a g protein coupled receptor |
EP1198569A1 (en) * | 1999-07-30 | 2002-04-24 | MERCK PATENT GmbH | G-protein coupled receptor and dna sequences thereof |
CA2382889A1 (en) * | 1999-08-27 | 2001-03-08 | Takuya Watanabe | Novel g protein-coupled receptor protein and dna thereof |
EP1207201A4 (en) * | 1999-08-27 | 2003-03-12 | Takeda Chemical Industries Ltd | Novel g protein-coupled receptor protein and dna thereof |
JP2003225088A (en) * | 1999-09-10 | 2003-08-12 | Meiji Seika Kaisha Ltd | Second human leukotriene b4 receptor and dna coding for the same |
US6998255B1 (en) | 1999-09-24 | 2006-02-14 | Solvay Pharmaceuticals B.V. | Human G-protein coupled receptor |
WO2001025269A2 (en) * | 1999-09-24 | 2001-04-12 | Solvay Pharmaceuticals B.V. | Human g-protein coupled receptor |
GB9923177D0 (en) * | 1999-09-30 | 1999-12-01 | Pfizer Ltd | Novel polypeptide |
GB9923890D0 (en) * | 1999-10-08 | 1999-12-08 | Pfizer Ltd | Novel polypeptide |
GB9923893D0 (en) * | 1999-10-08 | 1999-12-08 | Pfizer Ltd | Novel polypeptide |
GB9923888D0 (en) | 1999-10-08 | 1999-12-08 | Pfizer Ltd | Novel polypeptide |
GB9924960D0 (en) * | 1999-10-21 | 1999-12-22 | Pfizer Ltd | Novel polypeptide |
WO2001031014A2 (en) * | 1999-10-27 | 2001-05-03 | Pharmacia & Upjohn Company | G protein-coupled receptors expressed in human brain |
EP1096009B1 (en) * | 1999-10-29 | 2007-10-10 | Pfizer Limited | G-protein coupled receptor-like Polypeptide |
WO2001032865A1 (en) * | 1999-11-03 | 2001-05-10 | Merck Patent Gmbh | Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
CA2388865A1 (en) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Novel g protein-coupled receptors |
EP1242448A2 (en) * | 1999-11-17 | 2002-09-25 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human g protein-coupled receptors |
US7029857B1 (en) | 1999-12-17 | 2006-04-18 | H. Lundbeck A/S | Processes for obtaining compounds employing SNORF72 receptors |
AU2398501A (en) * | 1999-12-20 | 2001-07-03 | Banyu Pharmaceutical Co., Ltd. | Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26 |
CA2395416A1 (en) | 1999-12-23 | 2001-06-28 | Millennium Pharmaceuticals, Inc. | P2y12 receptor |
GB0001700D0 (en) * | 2000-01-25 | 2000-03-15 | Glaxo Group Ltd | Novel protein |
WO2001057524A1 (en) | 2000-02-04 | 2001-08-09 | Takeda Chemical Industries, Ltd. | Screening method |
AU2001252181A1 (en) * | 2000-03-14 | 2001-09-24 | Bayer Aktiengesellschaft | Regulation of human lipoxin a4 receptor-like protein |
WO2001068844A2 (en) * | 2000-03-17 | 2001-09-20 | Bayer Aktiengesellschaft | Regulation of human leukotriene b4-like g protein-coupled receptor |
EP1270589A4 (en) * | 2000-03-21 | 2004-09-29 | Yamanouchi Pharma Co Ltd | Novel leukotriene b4 receptor |
US20030087287A1 (en) * | 2000-03-28 | 2003-05-08 | Masanori Miwa | Novel g-protein-coupled receptor protein and dna thereof |
WO2001073023A1 (en) * | 2000-03-31 | 2001-10-04 | Helix Research Institute | Novel guanosine triphosphate-binding protein-coupled receptor gprv53, gene thereof and production and use of the same |
AU2001248755A1 (en) * | 2000-04-12 | 2001-10-23 | Takeda Chemical Industries Ltd. | Novel g protein-coupled receptor protein and dna thereof |
EP1178110A1 (en) * | 2000-08-01 | 2002-02-06 | Aventis Pharma Deutschland GmbH | EDG8 receptor for sphingosine 1-phosphate , its preparation and use |
WO2001081418A1 (en) * | 2000-04-27 | 2001-11-01 | Merck & Co., Inc. | New neuromedin u receptor nmur2 and nucleotides encoding it |
WO2001085786A2 (en) * | 2000-05-05 | 2001-11-15 | Wyeth | Human histamine h4 receptor |
US20030032784A1 (en) * | 2000-05-08 | 2003-02-13 | Peter Lind | Novel G protein-coupled receptors |
EP1282705A2 (en) * | 2000-05-09 | 2003-02-12 | Bayer Aktiengesellschaft | Endothelial differentiation gene 6-like g protein coupled receptor |
EP1287021A2 (en) * | 2000-05-18 | 2003-03-05 | Bayer Aktiengesellschaft | Human galanin receptor-like g protein coupled receptor |
EP1297128A2 (en) * | 2000-05-18 | 2003-04-02 | Incyte Genomics, Inc. | G-protein coupled receptors |
DK1287133T3 (en) * | 2000-05-18 | 2007-03-26 | Bayer Healthcare Ag | Regulation of human dopamine-like G protein-coupled receptor |
AU4171301A (en) | 2000-05-31 | 2001-12-11 | Ortho Mcneil Pharm Inc | Dnas encoding mammalian histamine receptor of the h4 subtype |
WO2002000719A2 (en) * | 2000-06-23 | 2002-01-03 | Tularik Inc. | Human and mouse g-protein couipled receptors |
WO2002002599A2 (en) * | 2000-06-30 | 2002-01-10 | Ingenium Pharmaceuticals Ag | HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF |
US6927041B2 (en) | 2000-07-06 | 2005-08-09 | Bayer Corporation | Human neuropeptide Y-like G protein-coupled receptor |
WO2002018590A2 (en) * | 2000-08-30 | 2002-03-07 | John Hopkins University School Of Medicine | Identification of activated receptors and ion channels |
AU2000276780A1 (en) * | 2000-10-02 | 2001-04-23 | Biofocus Discovery Limited | Cellular receptor mutations predicted by multiple-sequence-allignment |
ATE357457T1 (en) * | 2000-11-01 | 2007-04-15 | Astellas Pharma Inc | METHOD FOR SCREENING AN ANTIPLATE INHIBITOR |
AU2002212521B2 (en) * | 2000-11-07 | 2007-04-26 | Paradigm Therapeutics Limited | A "Bach" G protein coupled receptor polypeptide and polynucleotide encoding this receptor |
ES2280435T3 (en) | 2000-12-01 | 2007-09-16 | Astellas Pharma Inc. | METHOD OF EXPLORATION OF REMEDIES FOR DIABETES. |
AU2002222681A1 (en) * | 2000-12-19 | 2002-07-01 | Takeda Chemical Industries Ltd. | Novel transmembrane receptor-like proteins and dnas thereof |
US7157244B2 (en) | 2001-01-17 | 2007-01-02 | Schering Corporation | Adenosine receptor |
EP1382678B1 (en) * | 2001-04-25 | 2008-08-27 | Astellas Pharma Inc. | Guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same |
US6919176B2 (en) | 2001-05-07 | 2005-07-19 | Amgen Inc. | Polypeptides and nucleic acids associated with cancer |
CA2449553A1 (en) * | 2001-06-05 | 2002-12-19 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1 |
US6902902B2 (en) | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
WO2003087134A2 (en) | 2002-04-12 | 2003-10-23 | Schering Corporation | G-protein coupled receptor ligands and methods |
WO2003102159A2 (en) * | 2002-06-04 | 2003-12-11 | Curagen Corporation | Novel proteins and nucleic acids encoding same |
AU2003261874A1 (en) * | 2002-09-02 | 2004-03-29 | Takeda Pharmaceutical Company Limited | Adrenocortical hormone secretion controller |
US20050233304A1 (en) * | 2002-10-11 | 2005-10-20 | Yamanouchi Pharmaceutical Co., Ltd. | Method of screening remedy for renal failure |
US7056685B1 (en) | 2002-11-05 | 2006-06-06 | Amgen Inc. | Receptor ligands and methods of modulating receptors |
WO2004060282A2 (en) * | 2002-12-19 | 2004-07-22 | Synaptic Pharmaceutical Corporation | Uses of the snorf207 receptor |
US7083933B1 (en) | 2003-05-09 | 2006-08-01 | Prosidion Limited | Methods for identification of modulators of OSGPR116 activity |
US8791100B2 (en) | 2010-02-02 | 2014-07-29 | Novartis Ag | Aryl benzylamine compounds |
WO2018087285A1 (en) | 2016-11-10 | 2018-05-17 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Or10h1 antigen binding proteins and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL124808A0 (en) * | 1995-12-11 | 1999-01-26 | New England Medical Center Inc | Assay for and uses of peptide hormone receptor ligands |
WO1998038217A1 (en) * | 1997-02-27 | 1998-09-03 | Milt Teitler | Constitutively activated serotonin receptors |
WO1999024569A1 (en) * | 1997-11-11 | 1999-05-20 | Ono Pharmaceutical Co., Ltd. | Human lysophosphatidic acid receptor and use thereof |
-
1999
- 1999-10-13 IL IL14215399A patent/IL142153A0/en unknown
- 1999-10-13 CA CA002348688A patent/CA2348688A1/en not_active Abandoned
- 1999-10-13 KR KR1020017004630A patent/KR20010080882A/en not_active Application Discontinuation
- 1999-10-13 WO PCT/US1999/024065 patent/WO2000022131A2/en not_active Application Discontinuation
- 1999-10-13 NZ NZ510712A patent/NZ510712A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2000022131A3 (en) | 2001-02-22 |
CA2348688A1 (en) | 2000-04-20 |
KR20010080882A (en) | 2001-08-25 |
NZ510712A (en) | 2004-11-26 |
WO2000022131A2 (en) | 2000-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL142153A0 (en) | Non-endogenous, constitutively activated human g protein-coupled receptors | |
IL152136A0 (en) | Non-endogenous, constitutively activated known g protein-coupled receptors | |
IL149111A0 (en) | Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors | |
IL145761A0 (en) | Il-8 receptor antagonists | |
EP1200472A4 (en) | Odorant receptors | |
IL145762A0 (en) | Il-8 receptor antagonists | |
PL351946A1 (en) | Il-8 receptor antagonists | |
ZA200109627B (en) | IL-8 receptor antagonists. | |
EP1368378A4 (en) | Constitutively desensitized g protein-coupled receptors | |
AU1100300A (en) | Piperidyloxadiazoles as dopamine receptor antagonists | |
HK1042511A1 (en) | Non-endogenous, constitutively activated human g protein-coupled receptors | |
AU2574801A (en) | Selective iGLUR5 receptor antagonists | |
AU6006399A (en) | Novel g protein-coupled receptors | |
IL142362A0 (en) | Ureidopiperidine derivatives as selective human nk3 receptor antagonists | |
EP1194143A4 (en) | Il-8 receptor antagonists | |
AU2001238682A1 (en) | Human g protein-coupled receptors | |
EP1131335A4 (en) | 7tm receptor hlwar77 | |
EP1100813A4 (en) | HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb | |
IL137327A0 (en) | Orphan receptors | |
EP1185270A4 (en) | Il-8 receptor antagonists | |
AU5961201A (en) | Novel g protein-coupled receptors | |
IL160446A0 (en) | Endogenous constitutively activated g protein-coupled orphan receptors | |
ZA200110205B (en) | IL-8 receptor antagonists. | |
ZA200110203B (en) | IL-8 receptor antagonists. | |
AU2001249228A1 (en) | Human g protein-coupled receptors |